Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

282 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Incidence, Survival, and Risk Factors for Adults with Acute Myeloid Leukemia Not Otherwise Specified and Acute Myeloid Leukemia with Recurrent Genetic Abnormalities: Analysis of the Surveillance, Epidemiology, and End Results (SEER) Database, 2001-2013.
Song X, Peng Y, Wang X, Chen Y, Jin L, Yang T, Qian M, Ni W, Tong X, Lan J. Song X, et al. Acta Haematol. 2018;139(2):115-127. doi: 10.1159/000486228. Epub 2018 Feb 16. Acta Haematol. 2018. PMID: 29455198
Venetoclax plus hypomethylating agent for the salvage treatment of relapsing myeloid malignancies after hematopoietic stem cell transplantation: A multicenter retrospective study on behalf of the Zhejiang Cooperative Group for Blood and Marrow Transplantation.
Gao F, Gao Y, Luo Y, Yu J, Fu H, Lai X, Liu L, Ye B, Lan J, Song X, Lu Y, Chen L, Chen Y, Yu K, Huang H, Shi J, Zhao Y. Gao F, et al. Am J Hematol. 2022 Feb 1;97(2):E44-E47. doi: 10.1002/ajh.26405. Epub 2021 Nov 24. Am J Hematol. 2022. PMID: 34778993 Free article. No abstract available.
LncRNA-PAX8-AS1 Silencing Decreases Cell Viability, Enhances Apoptosis, and Suppresses Doxorubicin Resistance in Myeloid Leukemia via the miR-378g/ERBB2 Axis.
Song X, Chen Y, Peng Y, Wang X, Zheng S, Shi F, Lan J. Song X, et al. Evid Based Complement Alternat Med. 2022 Oct 6;2022:2295044. doi: 10.1155/2022/2295044. eCollection 2022. Evid Based Complement Alternat Med. 2022. Retraction in: Evid Based Complement Alternat Med. 2023 Jun 21;2023:9829428. doi: 10.1155/2023/9829428 PMID: 36248434 Free PMC article. Retracted.
Comparison of long-term outcomes between imatinib and dasatinib prophylaxis after allogeneic stem cell transplantation in patients with Philadelphia-positive acute lymphoblastic leukemia: A multicenter retrospective study.
Guan F, Yang L, Chen Y, Shi J, Song X, Lai X, Lu Y, Liu L, Ouyang G, Zhao Y, Yu J, Xu Y, Lan J, Fu H, Zhao Y, Qiu X, Zhu P, Cai Z, Huang H, Luo Y. Guan F, et al. Cancer. 2024 Jun 15;130(12):2139-2149. doi: 10.1002/cncr.35232. Epub 2024 Feb 5. Cancer. 2024. PMID: 38315517
Mismatched unrelated donors allogeneic hematopoietic stem cell transplantation with antithymocyte globulin for hematological malignancies: a multicenter retrospective study in China.
Li L, Chen Y, Chen T, Xu Y, Zhu P, Shi J, Zhai W, Zhao Y, Xu Y, Lai X, Yu J, Liu L, Song X, Yang T, Lu Y, Yang K, Feng Y, Ni X, Lan J, Qiu X, Zhang Y, Jiang S, Huang H, Jiang E, Zhang X, Luo Y. Li L, et al. Bone Marrow Transplant. 2024 Nov 8. doi: 10.1038/s41409-024-02454-5. Online ahead of print. Bone Marrow Transplant. 2024. PMID: 39516707
282 results